ReviewEmerging infectious diseases2010
Clostridium difficile bacteremia, Taiwan.
Review in Emerging infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 46 citations in OpenAlex.
- Extraintestinal Manifestations ofAntibiotics (Basel, Switzerland) · 2025Review
- [Clostridiodes difficile bacteraemia. First mexican case report].Revista medica del Instituto Mexicano del Seguro Social · 2024Article
- Concurrent and Subsequent Co-Infections ofMicroorganisms · 2022Review
- Polymicrobial bacteraemia withBMJ case reports · 2022Article
- An Atypical Case of MonomicrobialFrontiers in cellular and infection microbiology · 2022Article
- Proinflammatory Cytokines: Possible Accomplices for the Systemic Effects ofJournal of inflammation research · 2021Article
- Seeing C. diff Differently: A Case of Clostridioides difficile Bacteremia in Metastatic Melanoma.The American journal of case reports · 2020Article
- Clinical characteristics and prognostic factors of extraintestinal infection caused by Clostridioides difficile: analysis of 60 consecutive cases.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020Article
- ExtraintestinalAntibiotics (Basel, Switzerland) · 2020Article
- Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia?Infection · 2018Article
- Bacteremia and Septic Arthritis due to a Nontoxigenic Strain ofOpen forum infectious diseases · 2018Article
- Recurrent bacteremia and liver abscess caused by Clostridium difficile: A case report.Medicine · 2017Article
- Invading beyond bounds: extraintestinalBMJ case reports · 2017Article
- Article
- Article
- Successful Treatment ofCase reports in infectious diseases · 2017Article
- Clostridium difficile ribotype 078 cultured from post-surgical non-healing wound in a patient carrying ribotype 014 in the intestinal tract.Folia microbiologica · 2015Article
- Characteristics of patients with Clostridium difficile infection in Taiwan.Epidemiology and infection · 2013Article
- A case of Clostridium difficile bacteremia in a patient with loop ileostomy.Annals of laboratory medicine · 2013Article
- Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models.The Journal of infectious diseases · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To determine clinical characteristics and outcome of patients with Clostridium difficile bacteremia (CDB), we identified 12 patients with CDB in 2 medical centers in Taiwan; all had underlying systemic diseases. Five had gastrointestinal diseases or conditions, including pseudomembranous colitis (2 patients); 4 recalled diarrhea, but only 5 had recent exposure to antimicrobial drugs. Ten available isolates were susceptible to metronidazole and vancomycin. Five isolates had C. difficile toxin A or B. Of 5 patients who died, 3 died of CDB. Of 8 patients treated with metronidazole or vancomycin, only 1 died, and all 4 patients treated with other drugs died (12.5% vs. 100%; p = 0.01). C. difficile bacteremia, although uncommon, is thus associated with substaintial illness and death rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.